<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-3e93-d1af-013f-3f5c54b20354</uuid><title>HIV/AIDS: Medical Visit</title><shortTitle>HIV/AIDS Medical Visit</shortTitle><emeasureid>62</emeasureid><guid>f70b2984-af4a-4072-ae0d-cec677a7ff8f</guid><version>3</version><status>In Progress</status><nqfid extension="Not Applicable" root="2.16.840.1.113883.3.560.1"/><period uuid="40280381-3e93-d1af-013f-3f5c54c4035e"><startDate uuid="6685f3e4-7d6e-406c-9c67-6910a3115b14">00000101</startDate><stopDate uuid="88772c36-a8c4-4e82-8cd6-5f83e003af3b">00001231</stopDate></period><steward id="2.16.840.1.113883.3.464">National Committee for Quality Assurance</steward><developers><developer id="9ecfe128-b5ff-4c57-b9e8-47772ad6d406">National Committee for Quality Assurance/American Medical Association-convened Physician Consortium for Performance Improvement (R) (AMA-PCPI)</developer></developers><description>Percentage of patients, regardless of age, with a diagnosis of HIV/AIDS with at least two medical visits during the measurement year with a minimum of 90 days between each visit</description><copyright>Copyright 2013 National Committee for Quality Assurance (NCQA) and American Medical Association. All Rights Reserved.</copyright><disclaimer>Physician Performance Measures (Measures) and related data specifications have been developed by the American Medical Association (AMA) - convened Physician Consortium for Performance Improvement(R) (PCPI[R]) and the National Committee for Quality Assurance (NCQA). These Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA, (on behalf of the PCPI) or NCQA. Neither the AMA, PCPI, NCQA nor its members shall be responsible for any use of the Measures.&#xD;
&#xD;
THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND.&#xD;
&#xD;
Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, PCPI, NCQA and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT[R]) or other coding contained in the specifications.&#xD;
&#xD;
CPT(R) contained in the Measure specifications is copyright 2004-2013 American Medical Association. LOINC(R) copyright 2004-2013 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2013 International Health Terminology Standards Development Organisation. ICD-10 copyright 2013 World Health Organization. All Rights Reserved.&#xD;
&#xD;
Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>In general, patients with early-stage disease are seen at 3-month intervals to undergo routine medical evaluation and monitoring of CD4 cell count, viral load, and CBC. During the initial evaluation more frequent visits are common because there is so much information to transmit. Visits should also be more frequent when therapy is introduced and when the CD4 cell count is &lt;200/mm3 because complications are more likely. (Bartlett, 2004)</rationale><recommendations>Clinicians should schedule routine monitoring visits at least every 4 months for all HIV-infected patients who are clinically stable. (NYSDOH, 2004)</recommendations><improvementNotations>A higher score indicates better quality</improvementNotations><references><reference>Bartlett JG, Cheever LW, Johnson MP, Paauw DS [eds]. A Guide to Primary Care of People with HIV/AIDS. Rockville (MD): US Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau; 2004. 167 p. http://hab.hrsa.gov/tools/primarycareguide/ [Accessed August 24, 2007] </reference><reference>New York State Department of Health. Primary care approach to the HIV-infected patient. New York (NY): New York State Department of Health; 2004. 18 p. http://www.hivguidelines.org/Content.aspx?pageID=257 [Accessed August 24, 2007]    </reference></references><definitions>None</definitions><guidance>A medical visit is any visit with a health care professional who provides routine primary care for the patient with HIV/AIDS (may be but is not limited to a primary care clinician, ob/gyn, pediatrician, infectious disease specialist).</guidance><transmissionFormat>TBD</transmissionFormat><initialPatientPopDescription>All patients, regardless of age, with a diagnosis of HIV/AIDS seen within a 12 month period</initialPatientPopDescription><denominatorDescription>Equals initial patient population</denominatorDescription><denominatorExclusionsDescription>None</denominatorExclusionsDescription><numeratorDescription>Patients with at least two medical visits during the measurement year with a minimum of 90 days between each visit</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>None</denominatorExceptionsDescription><measurePopulationDescription>Not Applicable</measurePopulationDescription><measureObservationsDescription>Not Applicable</measureObservationsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity, and sex.</supplementalData><qualityMeasureSet uuid="6881a8c0-91e6-4420-8735-a4341ed9fb0b">Not Applicable</qualityMeasureSet>
<finalizedDate value="201403241429-0500"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3e93-d1af-013f-3f5c54c40355" name="ONC Administrative Sex"/><elementRef id="40280381-3e93-d1af-013f-3f5c54c40356" name="Race"/><elementRef id="40280381-3e93-d1af-013f-3f5c54c40357" name="Ethnicity"/><elementRef id="40280381-3e93-d1af-013f-3f5c54c40358" name="Payer"/></supplementalDataElements><measureGrouping><group sequence="1"><clause displayName="Initial Patient Population 1" type="initialPatientPopulation" uuid="7924BB67-8FE4-49C3-9EC8-B8B4D13D6564"><logicalOp displayName="AND" type="and"><relationalOp displayName="During" type="DURING"><elementRef displayName="HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013f-3f5c54c4035a" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013f-3f5c54c4035e" type="qdm"/></relationalOp><relationalOp displayName="Starts Before Or During" type="SBOD"><elementRef displayName="HIV : Diagnosis, Active" id="40280381-3e93-d1af-013f-3f5c54c40359" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013f-3f5c54c4035e" type="qdm"/></relationalOp></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="D13B0F26-ED20-45D7-8549-3FF2E9B13B56"><logicalOp displayName="AND" type="and"/></clause><clause displayName="Numerator 1" type="numerator" uuid="2027D47C-207D-4C04-A84F-9050BC49D1CD"><logicalOp displayName="AND" type="and"><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence A of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013f-3f5c54c4035b" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013f-3f5c54c4035e" type="qdm"/></relationalOp><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence B of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013f-3f5c54c4035c" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013f-3f5c54c4035e" type="qdm"/></relationalOp><relationalOp displayName="&gt;= 90 days Starts After End Of" operatorType="Greater Than or Equal To" quantity="90" type="SAE" unit="days"><elementRef displayName="Occurrence B of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013f-3f5c54c4035c" type="qdm"/><elementRef displayName="Occurrence A of HIV Visit : Encounter, Performed" id="40280381-3e93-d1af-013f-3f5c54c4035b" type="qdm"/></relationalOp></logicalOp></clause></group></measureGrouping><elementLookUp><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3e93-d1af-013f-3f5c54c40357" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3e93-d1af-013f-3f5c54c40357" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnosis, Active" id="40280381-3e93-d1af-013f-3f5c54c40359" name="HIV" oid="2.16.840.1.113883.3.464.1003.120.12.1003" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013f-3f5c54c40359" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3e93-d1af-013f-3f5c54c4035b" instance="Occurrence A" name="HIV Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1047" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013f-3f5c54c4035b" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3e93-d1af-013f-3f5c54c4035c" instance="Occurrence B" name="HIV Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1047" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013f-3f5c54c4035c" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3e93-d1af-013f-3f5c54c4035e" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3e93-d1af-013f-3f5c54c4035e" version="1"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3e93-d1af-013f-3f5c54c40355" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="AdministrativeSex" uuid="40280381-3e93-d1af-013f-3f5c54c40355" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3e93-d1af-013f-3f5c54c40358" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="SOP" uuid="40280381-3e93-d1af-013f-3f5c54c40358" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3e93-d1af-013f-3f5c54c40356" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3e93-d1af-013f-3f5c54c40356" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3e93-d1af-013f-3f5c54c4035a" name="HIV Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1047" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013f-3f5c54c4035a" version="1"/></elementLookUp><strata displayName="Stratification"><clause displayName="Stratum 1" type="stratum" uuid="40280381-3e93-d1af-013f-3f5c6738039a"><logicalOp displayName="AND" type="and"/></clause></strata></measure>
